White label ELPA - ClinicalTrials.eu

Study of 68Ga Satoreotide Trizoxetan PET/CT in Patients with High-Grade Neuroendocrine Lung Cancer

Not recruiting

2 1 1
Investigated Diseases:
- Neuroendocrine tumour of the lung
Investigated Drugs:
- Satoreotide Trizoxetan Gallium Ga-68
Study on the Effects of Filgotinib for Adults with Active Axial Spondyloarthritis

Not recruiting

3 1 1
Investigated Diseases:
- Axial spondyloarthritis
Investigated Drugs:
- Filgotinib
+9
Study on Semaglutide’s Effect on Reducing Alcohol Intake in Patients with Alcohol Use Disorder and Obesity

Not recruiting

2 1 1
Investigated Drugs:
- Saline
- Semaglutide
Study on the Effectiveness and Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa

Not recruiting

3 1
Investigated Diseases:
- Hidradenitis
Investigated Drugs:
- 4-[3-(Cyanomethyl)-3-(3′,5′-Dimethyl-1H,1’H-[4,4′-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide
+1
Study Comparing Docetaxel, Darolutamide, and ADT for Patients with Metastatic Hormone-Sensitive Prostate Cancer

Not recruiting

3 1 1 1
Investigated Drugs:
Study on the Effects of GLPG3667 for Adults with Dermatomyositis

Not recruiting

2 1
Investigated Diseases:
- Dermatomyositis
Investigated Drugs:
- Glpg3667 Fumarate
+4
Study of Olezarsen (ISIS 678354) for Patients with High Triglycerides and Heart Disease or Severe High Triglycerides

Not recruiting

3 1
Investigated Diseases:
- Hypertriglyceridaemia
- Arteriosclerosis
Investigated Drugs:
- Isis 678354 Sodium Salt
+7
Study on Ravulizumab for Protecting Chronic Kidney Disease Patients from Acute Kidney Injury After Heart Surgery

Not recruiting

3 1 1
Investigated Diseases:
- Acute kidney injury
Investigated Drugs:
- Ravulizumab
+2
Study on PRAX-562 for Children with Developmental and Epileptic Encephalopathies

Not recruiting

2 1
Study on Hydroxycarbamide Resistance in Patients with Polycythemia Vera Identified by AI Predictors

Not recruiting

3 1 1 1
Investigated Diseases:
- Polycythaemia vera
Investigated Drugs:
- Hydroxycarbamide

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies